WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'0401 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 8'0431 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 6'802  6'687  6'573  6'460  6'347  5'350  4'250  3'199 
Births 162  160  159  157  156  150  142  119 
Surviving infants 157  155  154  152  151  145  136  113 
Pop. less than 5 years 762  753  745  741  737  711  658  511 
Pop. less than 15 years 2'207  2'192  2'178  2'167  2'156  2'042  1'759  1'360 
Female 15-49 years 1'753  1'719  1'685  1'649  1'614  1'300  987  724 

Number of reported case

(Click for retrospective incidence data for Paraguay)
Diphtheria 10  14 
Japanese encephalitis
Measles 1'396  745 
Mumps 172  247  283  132  83  527 
Pertussis 81  44  11  24  115  652 
Polio*
Rubella 96 
Rubella (CRS)
Tetanus (neonatal) 38  99 
Tetanus (total) 10  12  13  50  188 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Paraguay)
Vaccine year result method % card seen                                                
BCG 2008  94  DHS   66  73  75  76  74  73  79  92  31 
DTP1 2008  96  DHS   66  73  76  77  76  74  73 
DTP3 2008  73  DHS   66  73  74  76  76  72  80  80  17 
HepB_BD         
HepB3          73  74  76  76  72 
Hib3          73  74  76  76  72 
JapEnc         
MCV 2008  76  DHS   66  75  74  77  77  71  92  71  19 
MCV2          64  62  65  64  63 
PCV1          73  99 
PCV3          73  82 
Pol3 2008  68  DHS   66  71  74  75  76  74  73  78  13 
Rota1          71  74  74  69 
Rota_last          70  72  72  57 
Rubella1          75  74  77  77  71 
TT2plus 1997  93  MCH     29  33  34  34  40  55  29 
PAB         
VAD1         
YFV          80  34  69  69  59 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Paraguay)
BCG 90  93  94  92  91  85  75  31 
DTP1 93  96  97  96  94  95  86  40 
DTP3 86  87  89  89  85  86  67  17 
HepB3 86  87  89  89  85 
HepB_BD
Hib3 86  87  89  89  85 
MCV 92  91  93  94  91  92  69  19 
MCV2 81  79  82  81  80 
PAB 85  85  85  85  74  47  66  26 
PnC3 73  82 
Pol3 80  83  84  85  80  86  64  14 
Rota_last 83  85  85  56 

Number of districts in the country 241  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
74 
   
/
|
|
\
Greater or equal to 90% 19
From 80 to 89% 13
From 50 to 79% 54
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HIB 1st contact; immunocompromized
HPV From March 2013
HepA 1st contact; Travelers
HepB 1st contact; +1, +6 months; Yes adults at risk and at birth for newborn at risk
IPV 2, 4, 6, 18 months; 4 years; Yes risk groups
Influenza 6-35 (x2) and >60 years; Yes and risk groups and PW
MMR 1, 4 years; Yes
MR >5 years; Yes not vaccinated and travellers
MenAC medical indication
MenACWY medical indication
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years Yes and risk groups
Rotavirus 2, 4 months; Yes
Td 1st contact; +1 month; +1, +1, +1 year; Yes CBAW and >Y7 and risk group
Tdap 10 years; Yes Pregnant women and risk groups
Typhoid 1st contact; international travelers
Varicella 15 months; Yes HCW and outbreaks
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  No  No  No  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016        1 año 
Nº of districts with microplans that include activities to raise immunization coverage number 241  240  238  238  234  233  232 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 241  240  238  241  234  233  232 
Nº districts with DTP3 coverage >=80% number 78  86  87  42  74  58  52 
% of districts with DTP3 coverage >=80% From 0 to 100% 32  36  37  17  32  25  22 
Nº districts with measles (MCV1) coverage >=95% number 33  27  39  37  27  35   
% of districts with MCV1 coverage >=95% From 0 to 100% 14  11  16  15  12  15   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.